Biophytis Stock (NASDAQ: BPTS) stock price, news, charts, stock research, profile.
Day Range0.450 - 0.530 | 52 Wk Range0.350 - 4.750 | Open / Close0.470 / 0.480 | Float / Outstanding- / 20.397M |
Vol / Avg.348.562K / 619.106K | Mkt Cap9.790M | P/E- | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-2.200 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-21 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.080 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biophytis (NASDAQ: BPTS) through any online brokerage.
Other companies in Biophytis’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Biophytis (NASDAQ: BPTS) was reported by HC Wainwright & Co. on Friday, February 3, 2023. The analyst firm set a price target for 15.00 expecting BPTS to rise to within 12 months (a possible 3025.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Biophytis (NASDAQ: BPTS) is $0.48 last updated February 8, 2023 at 8:51 PM UTC.
There are no upcoming dividends for Biophytis.
Biophytis’s FY earnings are confirmed for Tuesday, February 21, 2023.
There is no upcoming split for Biophytis.
Biophytis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biophytis Stock (NASDAQ: BPTS) stock price, news, charts, stock research, profile.
Day Range0.450 - 0.530 | 52 Wk Range0.350 - 4.750 | Open / Close0.470 / 0.480 | Float / Outstanding- / 20.397M |
Vol / Avg.348.562K / 619.106K | Mkt Cap9.790M | P/E- | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-2.200 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-21 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.080 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biophytis (NASDAQ: BPTS) through any online brokerage.
Other companies in Biophytis’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Biophytis (NASDAQ: BPTS) was reported by HC Wainwright & Co. on Friday, February 3, 2023. The analyst firm set a price target for 15.00 expecting BPTS to rise to within 12 months (a possible 3025.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Biophytis (NASDAQ: BPTS) is $0.48 last updated February 8, 2023 at 8:51 PM UTC.
There are no upcoming dividends for Biophytis.
Biophytis’s FY earnings are confirmed for Tuesday, February 21, 2023.
There is no upcoming split for Biophytis.
Biophytis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biophytis Stock (NASDAQ: BPTS) stock price, news, charts, stock research, profile.
Day Range0.450 - 0.530 | 52 Wk Range0.350 - 4.750 | Open / Close0.470 / 0.480 | Float / Outstanding- / 20.397M |
Vol / Avg.348.562K / 619.106K | Mkt Cap9.790M | P/E- | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-2.200 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-21 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.080 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biophytis (NASDAQ: BPTS) through any online brokerage.
Other companies in Biophytis’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Biophytis (NASDAQ: BPTS) was reported by HC Wainwright & Co. on Friday, February 3, 2023. The analyst firm set a price target for 15.00 expecting BPTS to rise to within 12 months (a possible 3025.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Biophytis (NASDAQ: BPTS) is $0.48 last updated February 8, 2023 at 8:51 PM UTC.
There are no upcoming dividends for Biophytis.
Biophytis’s FY earnings are confirmed for Tuesday, February 21, 2023.
There is no upcoming split for Biophytis.
Biophytis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biophytis Stock (NASDAQ: BPTS) stock price, news, charts, stock research, profile.
Day Range0.450 - 0.530 | 52 Wk Range0.350 - 4.750 | Open / Close0.470 / 0.480 | Float / Outstanding- / 20.397M |
Vol / Avg.348.562K / 619.106K | Mkt Cap9.790M | P/E- | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-2.200 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-21 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.080 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biophytis (NASDAQ: BPTS) through any online brokerage.
Other companies in Biophytis’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Biophytis (NASDAQ: BPTS) was reported by HC Wainwright & Co. on Friday, February 3, 2023. The analyst firm set a price target for 15.00 expecting BPTS to rise to within 12 months (a possible 3025.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Biophytis (NASDAQ: BPTS) is $0.48 last updated February 8, 2023 at 8:51 PM UTC.
There are no upcoming dividends for Biophytis.
Biophytis’s FY earnings are confirmed for Tuesday, February 21, 2023.
There is no upcoming split for Biophytis.
Biophytis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biophytis Stock (NASDAQ: BPTS) stock price, news, charts, stock research, profile.
Day Range0.450 - 0.530 | 52 Wk Range0.350 - 4.750 | Open / Close0.470 / 0.480 | Float / Outstanding- / 20.397M |
Vol / Avg.348.562K / 619.106K | Mkt Cap9.790M | P/E- | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-2.200 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-21 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.080 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biophytis (NASDAQ: BPTS) through any online brokerage.
Other companies in Biophytis’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Biophytis (NASDAQ: BPTS) was reported by HC Wainwright & Co. on Friday, February 3, 2023. The analyst firm set a price target for 15.00 expecting BPTS to rise to within 12 months (a possible 3025.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Biophytis (NASDAQ: BPTS) is $0.48 last updated February 8, 2023 at 8:51 PM UTC.
There are no upcoming dividends for Biophytis.
Biophytis’s FY earnings are confirmed for Tuesday, February 21, 2023.
There is no upcoming split for Biophytis.
Biophytis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biophytis Stock (NASDAQ: BPTS) stock price, news, charts, stock research, profile.
Day Range0.450 - 0.530 | 52 Wk Range0.350 - 4.750 | Open / Close0.470 / 0.480 | Float / Outstanding- / 20.397M |
Vol / Avg.348.562K / 619.106K | Mkt Cap9.790M | P/E- | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-2.200 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-21 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.080 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biophytis (NASDAQ: BPTS) through any online brokerage.
Other companies in Biophytis’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Biophytis (NASDAQ: BPTS) was reported by HC Wainwright & Co. on Friday, February 3, 2023. The analyst firm set a price target for 15.00 expecting BPTS to rise to within 12 months (a possible 3025.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Biophytis (NASDAQ: BPTS) is $0.48 last updated February 8, 2023 at 8:51 PM UTC.
There are no upcoming dividends for Biophytis.
Biophytis’s FY earnings are confirmed for Tuesday, February 21, 2023.
There is no upcoming split for Biophytis.
Biophytis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biophytis Stock (NASDAQ: BPTS) stock price, news, charts, stock research, profile.
Day Range0.450 - 0.530 | 52 Wk Range0.350 - 4.750 | Open / Close0.470 / 0.480 | Float / Outstanding- / 20.397M |
Vol / Avg.348.562K / 619.106K | Mkt Cap9.790M | P/E- | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-2.200 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-21 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.080 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biophytis (NASDAQ: BPTS) through any online brokerage.
Other companies in Biophytis’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Biophytis (NASDAQ: BPTS) was reported by HC Wainwright & Co. on Friday, February 3, 2023. The analyst firm set a price target for 15.00 expecting BPTS to rise to within 12 months (a possible 3025.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Biophytis (NASDAQ: BPTS) is $0.48 last updated February 8, 2023 at 8:51 PM UTC.
There are no upcoming dividends for Biophytis.
Biophytis’s FY earnings are confirmed for Tuesday, February 21, 2023.
There is no upcoming split for Biophytis.
Biophytis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biophytis Stock (NASDAQ: BPTS) stock price, news, charts, stock research, profile.
Day Range0.450 - 0.530 | 52 Wk Range0.350 - 4.750 | Open / Close0.470 / 0.480 | Float / Outstanding- / 20.397M |
Vol / Avg.348.562K / 619.106K | Mkt Cap9.790M | P/E- | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-2.200 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-21 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.080 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biophytis (NASDAQ: BPTS) through any online brokerage.
Other companies in Biophytis’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Biophytis (NASDAQ: BPTS) was reported by HC Wainwright & Co. on Friday, February 3, 2023. The analyst firm set a price target for 15.00 expecting BPTS to rise to within 12 months (a possible 3025.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Biophytis (NASDAQ: BPTS) is $0.48 last updated February 8, 2023 at 8:51 PM UTC.
There are no upcoming dividends for Biophytis.
Biophytis’s FY earnings are confirmed for Tuesday, February 21, 2023.
There is no upcoming split for Biophytis.
Biophytis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Biophytis Stock (NASDAQ: BPTS) stock price, news, charts, stock research, profile.
Day Range0.450 - 0.530 | 52 Wk Range0.350 - 4.750 | Open / Close0.470 / 0.480 | Float / Outstanding- / 20.397M |
Vol / Avg.348.562K / 619.106K | Mkt Cap9.790M | P/E- | 50d Avg. Price0.460 |
Div / Yield (Forward)- / -% | Payout Ratio- | Total Float- | EPS-2.200 |
FY 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | (EXPECTED)2023-02-21 | ||||||
REV |
H1 2022 | Est. | Actual | Surprise | ||||
---|---|---|---|---|---|---|---|
EPS | -0.080 | ||||||
REV | 0 |
Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
---|
You can purchase shares of Biophytis (NASDAQ: BPTS) through any online brokerage.
Other companies in Biophytis’s space includes: Immuron (NASDAQ:IMRN), Biocept (NASDAQ:BIOC), Quoin Pharmaceuticals (NASDAQ:QNRX), Synaptogenix (NASDAQ:SNPX) and T2 Biosystems (NASDAQ:TTOO).
The latest price target for Biophytis (NASDAQ: BPTS) was reported by HC Wainwright & Co. on Friday, February 3, 2023. The analyst firm set a price target for 15.00 expecting BPTS to rise to within 12 months (a possible 3025.00% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Biophytis (NASDAQ: BPTS) is $0.48 last updated February 8, 2023 at 8:51 PM UTC.
There are no upcoming dividends for Biophytis.
Biophytis’s FY earnings are confirmed for Tuesday, February 21, 2023.
There is no upcoming split for Biophytis.
Biophytis is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.